Brief: Venus Medtech Hangzhou Says HY Revenue Rmb255.6 Million
31/08/2023 14:40
Aug 31 (Reuters) - Venus Medtech Hangzhou Inc 2500.HK :
* HY REVENUE RMB255.6 MILLION VERSUS RMB210 MILLION
* HY LOSS ATTRIBUTABLE RMB350.2 MILLION VERSUS LOSS
RMB199.9
MILLION
Source text for Eikon: ID:nHKS5Ln03G
Further company coverage: 2500.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Venus Medtech (Hangzhou)
See all newsBrief: Venus Medtech Hangzhou To Issue 184.5 Million Shares And HK$379.7 Million Convertible Bonds
Brief: Venus Medtech Hangzhou Says Six-Month Revenue Rmb135.5 Million
Brief: Venus Medtech Hangzhou Says Liqiao Ma Resigns As Executive Director
Brief: Venus Medtech Hangzhou Logs FY Revenue RMB 306.8 Mln
Brief: Venus Medtech Says Unaware Of Any Info Needing Disclosure To Avoid False Market